Press Releases March 25, 2026 01:17 AM

Yimutian Inc. Announces Resignation of Independent Director

Yimutian Inc. announces the resignation of independent director Junchen Sun effective March 17, 2026.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
YMT

Yimutian Inc., a leading agricultural B2B platform in China listed on NASDAQ, announced the resignation of independent director Junchen Sun for personal reasons. The company is actively seeking a replacement, with oversight from its Nominating and Corporate Governance Committee, and will disclose updates as required by SEC and NASDAQ regulations.

Yimutian Inc. Announces Resignation of Independent Director
YMT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Independent director Junchen Sun resigned from Yimutian Inc.'s Board due to personal reasons effective March 17, 2026.
  • The company's Nominating and Corporate Governance Committee is managing the search for a new independent director.
  • Yimutian Inc. is focused on digitalizing China’s agricultural product supply chain to improve efficiency and transparency.

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. (NASDAQ: YMT) (the “Company”) announced that Junchen Sun, an independent director of the Company’s Board of Directors, has resigned from the Board, effective March 17, 2026.

Mr. Sun’s decision to resign is due to personal reasons. The Company and the Board would like to thank Mr. Sun for his service and contributions to the Company during his tenure on the Board.

The Nominating and Corporate Governance Committee of the Board will oversee the process for identifying a potential replacement, and the Company will make appropriate disclosures in accordance with applicable law and the rules of the U.S. Securities and Exchange Commission and the listing standards of Nasdaq.

About Yimutian Inc.
Yimutian Inc, is a leading agricultural B2B platform in mainland China. Over a decade, the company has been dedicated to digitalizing China’s agricultural product supply chain infrastructure to streamline the agricultural product transaction process, and making it efficient, transparent, secure, and convenient.For more information, please visit https://ir.ymt.com/

Forward-Looking Statements
This press release contains forward-looking statements. These statements are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, these forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Investor & Media Contacts
Investor Relations: ir@ymt360.com  |  +86 10 5708 6561
Media: pr@ymt360.com


Risks

  • Potential delay or challenges in appointing a qualified replacement director may impact corporate governance.
  • Uncertainties related to forward-looking statements reflecting operational and market risks inherent to Yimutian's business in agricultural technology and B2B supply chains.
  • Market sensitivity to governance changes could affect investor confidence in the agricultural tech sector.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026